143 related articles for article (PubMed ID: 16766525)
1. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix.
Andreotti G; Méndez BL; Amodeo P; Morelli MA; Nakamuta H; Motta A
J Biol Chem; 2006 Aug; 281(34):24193-203. PubMed ID: 16766525
[TBL] [Abstract][Full Text] [Related]
2. Solution structure and biological activity of recombinant salmon calcitonin S-sulfonated analog.
Wang Y; Dou H; Cao C; Zhang N; Ma J; Mao J; Wu H
Biochem Biophys Res Commun; 2003 Jun; 306(2):582-9. PubMed ID: 12804605
[TBL] [Abstract][Full Text] [Related]
3. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
4. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
5. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
Hilton JM; Dowton M; Houssami S; Sexton PM
J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
[TBL] [Abstract][Full Text] [Related]
6. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of salmon calcitonin.
Meyer JP; Pelton JT; Hoflack J; Saudek V
Biopolymers; 1991 Feb; 31(2):233-41. PubMed ID: 2043752
[TBL] [Abstract][Full Text] [Related]
8. Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography.
Johansson E; Hansen JL; Hansen AM; Shaw AC; Becker P; Schäffer L; Reedtz-Runge S
J Biol Chem; 2016 Jun; 291(26):13689-98. PubMed ID: 27189946
[TBL] [Abstract][Full Text] [Related]
9. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
Rawat A; Kumar D
J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
[TBL] [Abstract][Full Text] [Related]
10. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
11. Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations.
Motta A; Pastore A; Goud NA; Castiglione Morelli MA
Biochemistry; 1991 Oct; 30(43):10444-50. PubMed ID: 1931969
[TBL] [Abstract][Full Text] [Related]
12. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin.
Andreotti G; Motta A
J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801
[TBL] [Abstract][Full Text] [Related]
13. A 1H NMR study of human calcitonin in solution.
Motta A; Temussi PA; Wünsch E; Bovermann G
Biochemistry; 1991 Mar; 30(9):2364-71. PubMed ID: 2001366
[TBL] [Abstract][Full Text] [Related]
14. Conformational flexibility and biological activity of salmon calcitonin.
Epand RM; Epand RF; Orlowski RC; Seyler JK; Colescott RL
Biochemistry; 1986 Apr; 25(8):1964-8. PubMed ID: 3707923
[TBL] [Abstract][Full Text] [Related]
15. Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling.
Pham V; Dong M; Wade JD; Miller LJ; Morton CJ; Ng HL; Parker MW; Sexton PM
J Biol Chem; 2005 Aug; 280(31):28610-22. PubMed ID: 15929987
[TBL] [Abstract][Full Text] [Related]
16. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of a human calcitonin analog elucidated by NMR and distance geometry calculations.
Katahira R; Doi M; Kyogoku Y; Yamada-Nosaka A; Yamasaki K; Takai M; Kobayashi Y
Int J Pept Protein Res; 1995 Apr; 45(4):305-11. PubMed ID: 7601602
[TBL] [Abstract][Full Text] [Related]
18. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
[TBL] [Abstract][Full Text] [Related]
19. Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.
Amodeo P; Motta A; Strazzullo G; Castiglione Morelli MA
J Biomol NMR; 1999 Feb; 13(2):161-74. PubMed ID: 10070757
[TBL] [Abstract][Full Text] [Related]
20. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids.
Epand RM; Epand RF; Orlowski RC; Schlueter RJ; Boni LT; Hui SW
Biochemistry; 1983 Oct; 22(22):5074-84. PubMed ID: 6652057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
